financetom
Business
financetom
/
Business
/
Australia social media teen ban software trial organisers say the tech works
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Australia social media teen ban software trial organisers say the tech works
Jun 19, 2025 9:14 PM

*

Australia plans to block under-16s from social media in

December

*

Trial finds 'no significant tech barriers' to ban

*

Trial organisers say age identification software effective

By Byron Kaye

SYDNEY, June 20 (Reuters) - Some age-checking

applications collect too much data and no product works 100% of

the time, but using software to enforce a teenage social media

ban can work in Australia, the head of the world's biggest trial

of the technology said on Friday.

The view from the government-commissioned Age Assurance

Technology Trial of more than 1,000 Australian school students

and hundreds of adults is a boost to the country's plan to keep

under 16s off social media.

From December, in a world first ban, companies like Facebook

and Instagram owner Meta, Snapchat and TikTok

must prove they are taking reasonable steps to block young

people from their platforms or face a fine of up A$49.5 million

($32 million).

Since the Australian government announced the legislation

last year, child protection advocates, tech industry groups and

children themselves have questioned whether the ban can be

enforced due to workarounds like Virtual Private Networks, which

obscure an internet user's location.

"Age assurance can be done in Australia privately,

efficiently and effectively," said Tony Allen, CEO of the Age

Check Certification Scheme, the UK-based organisation overseeing

the Australian trial.

The trial found "no significant tech barriers" to rolling

out a software-based scheme in Australia, although there was "no

one-size-fits-all solution, and no solution that worked

perfectly in all deployments," Allen added in an online

presentation.

Allen noted that some age-assurance software firms "don't

really know at this stage what data they may need to be able to

support law enforcement and regulators in the future.

"There's a risk there that they could be inadvertently

over-collecting information that wouldn't be used or needed."

Organisers of the trial, which concluded earlier this month,

gave no data findings and offered only a broad overview which

did not name individual products. They will deliver a report to

the government next month which officials have said will inform

an industry consultation ahead of the December deadline.

A spokesperson for the office of the eSafety Commissioner,

which will advise the government on how to implement the ban,

said the preliminary findings were a "useful indication of the

likely outcomes from the trial.

"We are pleased to see the trial suggests that age assurance

technologies, when deployed the right way and likely in

conjunction with other techniques and methods, can be private,

robust and effective," the spokesperson said.

The Australian ban is being watched closely around the

world with several governments exploring ways to

limit children's exposure

to social media.

($1 = 1.5427 Australian dollars)

(Additional reporting by Cordelia Hsu; Editing by Kate

Mayberry)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance
Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance
Jul 17, 2024
Elevance Health Inc.  reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion.  The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend and growth in CarelonRx product revenue related to members served. Related: Morgan Stanley Says Elevance Health’s Growth Attributed To Consistent Performance But Undervalued....
Prologis raises annual core FFO forecast on better demand, data center strength
Prologis raises annual core FFO forecast on better demand, data center strength
Jul 17, 2024
(Reuters) - Warehouse-focused real estate investment trust (REIT) Prologis ( PLD ) raised the lower end of its full-year forecast for core funds from operations (FFO) on Wednesday, banking on better demand and strength from data centers. Prologis ( PLD ), which focuses on logistics real estate, expects its 2024 core FFO to be between $5.39 and $5.47 per share,...
Massimo to Install Automated Vehicle Assembly Robot Line at Texas Factory
Massimo to Install Automated Vehicle Assembly Robot Line at Texas Factory
Jul 17, 2024
09:19 AM EDT, 07/17/2024 (MT Newswires) -- Massimo Group ( MAMO ) said Wednesday it will install a new automated vehicle assembly robot line at its Garland, Texas, factory in the coming weeks to manufacture its all-terrain and utility terrain vehicles. The new production line is expected to increase assembly efficiency by 50%, according to the company. It will integrate...
Adidas and Thom Browne fight in UK court over striped trademarks
Adidas and Thom Browne fight in UK court over striped trademarks
Jul 17, 2024
LONDON (Reuters) - Athletic wear giant Adidas and fashion house Thom Browne resumed their legal battle on Wednesday, with London's High Court hearing the latest round of a global dispute focused on their competing striped trademarks. New York designer Thom Browne, who regularly uses a four-bar stripe pattern, sued Adidas in London in 2021 to revoke several trademarks featuring Adidas'...
Copyright 2023-2026 - www.financetom.com All Rights Reserved